Search tips
Search criteria 


Logo of thoraxThoraxVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Thorax. 1993 December; 48(12): 1211–1217.
PMCID: PMC464971

How many times per day should peak expiratory flow rates be assessed when investigating occupational asthma?


BACKGROUND--Serial peak expiratory flow rate (PEF) recording has been advocated as a sensitive and specific means of confirming work related asthma. The optimum number of recordings per day to achieve the best between-reader and within-reader reproducibility and sensitivity/specificity ratio compared with the final diagnosis determined by specific inhalation challenges is unknown. METHODS--PEF recording was carried out every two hours in 74 subjects referred for possible occupational asthma. Specific inhalation challenges performed in a hospital laboratory or at the workplace (positive in 33 subjects and negative in 41) were considered the gold standard. The duration of monitoring at work and away from work was at least two weeks each. Graphs of PEF recordings were generated in four different ways: every two hours, four times/day, three times/day, and every morning and evening. The graphs were assessed by three readers in three different centres in a blind manner. Furthermore, one third of each type of graph was read blind by the same reader one week after the initial interpretation. RESULTS--Agreement between the three readers was a little more frequent (82%) in the case of the every two hour readings than for the other types of readings (70% v 77%). Agreement between at least two of the three readers occurred in 73% of positive challenges (sensitivity) and in 78% of negative challenges (specificity) for every two hour readings. The figures varied from 61% to 70% for positive challenges and from 78% to 88% for negative challenges for the other types of readings. Within-subject reproducibility from one reading to the next (one week apart) was excellent (83% to 100%). CONCLUSIONS--Recording PEF every two hours results in a slightly more satisfactory agreement between readers and in concordance in terms of sensitivity/specificity than less frequent PEF readings, although the four times a day assessment is almost as satisfactory.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Turner-Warwick M. On observing patterns of airflow obstruction in chronic asthma. Br J Dis Chest. 1977 Apr;71(2):73–86. [PubMed]
  • Hetzel MR, Clark TJ, Branthwaite MA. Asthma: analysis of sudden deaths and ventilatory arrests in hospital. Br Med J. 1977 Mar 26;1(6064):808–811. [PMC free article] [PubMed]
  • Woolcock A, Rubinfeld AR, Seale JP, Landau LL, Antic R, Mitchell C, Rea HH, Zimmerman P. Thoracic society of Australia and New Zealand. Asthma management plan, 1989. Med J Aust. 1989 Dec 4;151(11-12):650–653. [PubMed]
  • Hargreave FE, Dolovich J, Newhouse MT. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol. 1990 Jun;85(6):1098–1111. [PubMed]
  • Burge PS, O'Brien IM, Harries MG. Peak flow rate records in the diagnosis of occupational asthma due to isocyanates. Thorax. 1979 Jun;34(3):317–323. [PMC free article] [PubMed]
  • Burge PS, O'Brien IM, Harries MG. Peak flow rate records in the diagnosis of occupational asthma due to colophony. Thorax. 1979 Jun;34(3):308–316. [PMC free article] [PubMed]
  • Cockcroft DW, Cartier A, Jones G, Tarlo SM, Dolovich J, Hargreave FE. Asthma caused by occupational exposure to a furan-based binder system. J Allergy Clin Immunol. 1980 Dec;66(6):458–463. [PubMed]
  • Cartier A, Pineau L, Malo JL. Monitoring of maximum expiratory peak flow rates and histamine inhalation tests in the investigation of occupational asthma. Clin Allergy. 1984 Mar;14(2):193–196. [PubMed]
  • Cartier A, Malo JL, Forest F, Lafrance M, Pineau L, St-Aubin JJ, Dubois JY. Occupational asthma in snow crab-processing workers. J Allergy Clin Immunol. 1984 Sep;74(3 Pt 1):261–269. [PubMed]
  • Malo JL, Cartier A. Occupational asthma in workers of a pharmaceutical company processing spiramycin. Thorax. 1988 May;43(5):371–377. [PMC free article] [PubMed]
  • Bardy JD, Malo JL, Séguin P, Ghezzo H, Desjardins J, Dolovich J, Cartier A. Occupational asthma and IgE sensitization in a pharmaceutical company processing psyllium. Am Rev Respir Dis. 1987 May;135(5):1033–1038. [PubMed]
  • Smith AB, Bernstein DI, London MA, Gallagher J, Ornella GA, Gelletly SK, Wallingford K, Newman MA. Evaluation of occupational asthma from airborne egg protein exposure in multiple settings. Chest. 1990 Aug;98(2):398–404. [PubMed]
  • Côté J, Kennedy S, Chan-Yeung M. Sensitivity and specificity of PC20 and peak expiratory flow rate in cedar asthma. J Allergy Clin Immunol. 1990 Mar;85(3):592–598. [PubMed]
  • Côté J, Kennedy S, Chan-Yeung M. Sensitivity and specificity of PC20 and peak expiratory flow rate in cedar asthma. J Allergy Clin Immunol. 1990 Mar;85(3):592–598. [PubMed]
  • Venables KM, Burge PS, Davison AG, Newman Taylor AJ. Peak flow rate records in surveys: reproducibility of observers' reports. Thorax. 1984 Nov;39(11):828–832. [PMC free article] [PubMed]
  • Lam S, Wong R, Yeung M. Nonspecific bronchial reactivity in occupational asthma. J Allergy Clin Immunol. 1979 Jan;63(1):28–34. [PubMed]
  • Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977 May;7(3):235–243. [PubMed]
  • Malo JL, Pineau L, Cartier A, Martin RR. Reference values of the provocative concentrations of methacholine that cause 6% and 20% changes in forced expiratory volume in one second in a normal population. Am Rev Respir Dis. 1983 Jul;128(1):8–11. [PubMed]
  • Chan-Yeung M, Barton GM, MacLean L, Grzybowski S. Occupational asthma and rhinitis due to Western red cedar (Thuja plicata). Am Rev Respir Dis. 1973 Nov;108(5):1094–1102. [PubMed]
  • Pepys J, Hutchcroft BJ. Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis. 1975 Dec;112(6):829–859. [PubMed]
  • Cloutier Y, Lagier F, Lemieux R, Blais MC, St-Arnaud C, Cartier A, Malo JL. New methodology for specific inhalation challenges with occupational agents in powder form. Eur Respir J. 1989 Sep;2(8):769–777. [PubMed]
  • Vandenplas O, Malo JL, Cartier A, Perreault G, Cloutier Y. Closed-circuit methodology for inhalation challenge tests with isocyanates. Am Rev Respir Dis. 1992 Mar;145(3):582–587. [PubMed]
  • Bérubé D, Cartier A, L'Archevêque J, Ghezzo H, Malo JL. Comparison of peak expiratory flow rate and FEV1 in assessing bronchomotor tone after challenges with occupational sensitizers. Chest. 1991 Apr;99(4):831–836. [PubMed]
  • Malo JL, Ghezzo H, L'Archevêque J, Lagier F, Perrin B, Cartier A. Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Respir Dis. 1991 Mar;143(3):528–532. [PubMed]
  • Cartier A, Grammer L, Malo JL, Lagier F, Ghezzo H, Harris K, Patterson R. Specific serum antibodies against isocyanates: association with occupational asthma. J Allergy Clin Immunol. 1989 Oct;84(4 Pt 1):507–514. [PubMed]
  • Chan-Yeung M, Lam S, Koener S. Clinical features and natural history of occupational asthma due to western red cedar (Thuja plicata). Am J Med. 1982 Mar;72(3):411–415. [PubMed]
  • Mapp CE, Corona PC, De Marzo N, Fabbri L. Persistent asthma due to isocyanates. A follow-up study of subjects with occupational asthma due to toluene diisocyanate (TDI). Am Rev Respir Dis. 1988 Jun;137(6):1326–1329. [PubMed]
  • Malo JL, Boulet LP, Dewitte JD, Cartier A, L'Archevêque J, Côté J, Bédard G, Boucher S, Champagne F, Tessier G, et al. Quality of life of subjects with occupational asthma. J Allergy Clin Immunol. 1993 Jun;91(6):1121–1127. [PubMed]
  • Malo JL, Dewitte JD, Cartier A, Ghezzo H, L'Archevêque J, Boulet LP, Côté J, Bédard G, Boucher S, Champagne F, et al. Le système québécois d'indemnisation pour asthme professionnel. Description, efficacité et coûts. Rev Mal Respir. 1993;10(4):313–323. [PubMed]

Articles from Thorax are provided here courtesy of BMJ Group